Capital Group Investment Management Pte. Ltd. Karuna Therapeutics, Inc. Transaction History

Capital Group Investment Management Pte. Ltd.

  • $444 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$161.01 - $317.85 $240,548 - $474,867
1,494 Added 65.47%
3,776 $1.2 Million
Q2 2023

Aug 11, 2023
BUY
$176.32 - $240.22 $402,362 - $548,182
2,282 New
2,282 $494,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Capital Group Investment Management Pte. Ltd. Portfolio

Follow Capital Group Investment Management Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Investment Management Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Investment Management Pte. Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email